Cargando…

An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

The development of blood-based biomarkers of Alzheimer’s disease (AD) pathology as tools for screening the general population, and as the first step in a multistep process to determine which non-demented individuals are at greatest risk of developing AD dementia, is essential. Proteins that are refl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Danni, Mielke, Michelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908531/
https://www.ncbi.nlm.nih.gov/pubmed/31833025
http://dx.doi.org/10.1007/s40120-019-00164-5

Ejemplares similares